Acute Respiratory Distress Syndrome (ARDS) Market Size and Trends Analysis
Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients. The major complication in ARDS is marked by leakage of fluid into the lungs, making breathing difficult or impossible.
The causes of ARDS are divided into two categories: direct or indirect injuries to the lung. Some of the direct injuries to the lung include pneumonia, aspiration, trauma, and others. Whereas the indirect injuries to the lung include inflammation of the pancreas, severe infection (also known as sepsis), blood transfusions, burns, and medication reactions.
DelveInsight's "Acute Respiratory Distress Syndrome (ARDS) Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Acute Respiratory Distress Syndrome (ARDS) Market, historical and forecasted epidemiology, the pipeline insight as well as the Acute Respiratory Distress Syndrome (ARDS) market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Acute Respiratory Distress Syndrome (ARDS) Market Key Facts
As per DelveInsight, the total incident population of ARDS in the 7MM was 799,872 in 2017.
DelveInsight estimates show a higher incidence of ARDS in the United States, with an estimated number of 495,655 cases in 2017.
Acute Respiratory Distress Syndrome (ARDS) Market Size and Trends Analysis
The market size of Acute Respiratory Distress Syndrome (ARDS) is expected to increase during the forecast period owing to the launch of upcoming therapies and is expected to increase at a significant rate during the study period.
The Acute Respiratory Distress Syndrome (ARDS) market analysis section of the report helps to build the detailed comprehension of the historic, current and forecasted Acute Respiratory Distress Syndrome (ARDS) market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
Acute Respiratory Distress Syndrome (ARDS) Epidemiology Forecast
The Acute Respiratory Distress Syndrome (ARDS) epidemiology section covers insights about historical and current Acute Respiratory Distress Syndrome (ARDS) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Acute Respiratory Distress Syndrome (ARDS) Pipeline Analysis and Key Companies
The Acute Respiratory Distress Syndrome (ARDS) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Respiratory Distress Syndrome (ARDS) market or expected to get launched in the market during the study period. The analysis covers the Acute Respiratory Distress Syndrome (ARDS) market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key companies in the Acute Respiratory Distress Syndrome (ARDS) market include:
Faron Pharmaceuticals
BioMarck Pharmaceuticals
Athersys
Techpool Bio-Pharma
Apeiron Biologics
APEPTICO Forschung und Entwicklung GmbH
United Therapeutics
Bayer
And many others.
For more details on Acute Respiratory Distress Syndrome (ARDS) Market Insights, Epidemiology, and Pipeline Analysis, visit: https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market